 
MAINE STATE LEGISLATURE  
 
 
 
The following document is provided by the 
LAW AND LEGISLATIVE DIGITAL LIBRARY  
at the Maine State Law and Legislative Reference Library 
http://legislature.m aine.gov/lawlib 
 
 
 
 
 
 
 
 
 
 
Reproduced from electronic originals 
(may include minor formatting diffe rences from printed original) 
 
 
Printed on recycled paper130th MAINE LEGISLATURE
SECOND REGULAR SESSION-2022
Legislative Document No. 1956
H.P. 1455 House of Representatives, February 3, 2022
An Act To Update the Consumer Credit Laws Related to Legal 
Funding Practices
Approved for introduction by a majority of the Legislative Council pursuant to Joint Rule 
203.
Received by the Clerk of the House on February 1, 2022.  Referred to the Committee on 
Health Coverage, Insurance and Financial Services pursuant to Joint Rule 308.2 and ordered 
printed pursuant to Joint Rule 401.
ROBERT B. HUNT
Clerk
Presented by Representative MORRIS of Turner.
Cosponsored by Senator BALDACCI of Penobscot and
Senator: KEIM of Oxford.

Page 1 - 130LR2325(01)1Be it enacted by the People of the State of Maine as follows:
2Sec. 1.  9-A MRSA §12-102, sub-§2, as enacted by PL 2007, c. 394, §1 and affected 
3 by §3, is amended to read:
42.   "Legal funding" means a transaction in which a company makes a cash payment to 
5 a consumer in exchange for the right to receive an amount out of the potential proceeds of 
6 any realized settlement, judgment, award or verdict the consumer may receive in a civil 
7 claim or action.  If no proceeds in the civil claim or action are received, the consumer is 
8 not required to pay the company.  a nonrecourse transaction in which a litigation funding 
9 provider provides funds to a consumer in exchange for:
10 A.  An assignment of the consumer's contingent right to receive an amount of the 
11 potential proceeds a consumer may receive in a civil claim or action; or
12 B.  An agreement to pay the litigation funding provider interest or other fees for the 
13 legal funding provided.
14 "Legal funding" does not include legal services provided to a consumer on a contingency 
15 fee basis or advanced legal costs when such services or costs are provided by an attorney 
16 representing the consumer in accordance with the Maine Rules of Professional Conduct.
17Sec. 2.  9-A MRSA §12-102, sub-§3, as enacted by PL 2007, c. 394, §1 and affected 
18 by §3, is amended to read:
193.   "Litigation funding provider" means a person or entity, wherever located, engaged 
20 in the business of legal funding or that provides legal funding to a consumer.
21Sec. 3.  9-A MRSA §12-103, sub-§4 is enacted to read:
224.   This article does not apply to legal funding provided to a commercial entity in 
23 support of commercial litigation, except for matters arising from a personal injury claim or 
24 an aggregation of personal injury claims, whether by subrogation, assignment or any other 
25 basis.
26Sec. 4.  9-A MRSA §12-103, sub-§5 is enacted to read:
275.   This article applies to a class action.
28Sec. 5.  9-A MRSA §12-104, sub-§9, ¶C, as enacted by PL 2007, c. 394, §1 and 
29 affected by §3, is amended to read:
30 C.  All proceeds of the civil claim or action will be disbursed via the attorney's trust 
31 account; and
32Sec. 6.  9-A MRSA §12-104, sub-§9, ¶D, as enacted by PL 2007, c. 394, §1 and 
33 affected by §3, is amended to read:
34 D.  The attorney is following written instructions of the consumer with regard to the 
35 legal funding. ;
36Sec. 7.  9-A MRSA §12-104, sub-§9, ¶E is enacted to read:
37 E.  The attorney has not received or been paid a referral fee or any other consideration 
38 from the litigation funding provider; and
39Sec. 8.  9-A MRSA §12-104, sub-§9, ¶F is enacted to read:
Page 2 - 130LR2325(01)1 F.  The attorney has not provided or paid a referral fee or any other consideration to the 
2 litigation funding provider.
3Sec. 9.  9-A MRSA §12-104, sub-§12 is enacted to read:
412.  All contracts for legal funding must contain the following in at least 12-point bold 
5 type to read:
6 "IF THERE IS NO RECOVERY OF ANY MONEY FROM YOUR 
7 LEGAL CLAIM OR IF THERE IS NOT ENOUGH MONEY TO 
8 SATISFY THE PORTION ASSIGNED TO [INSERT NAME OF THE 
9 LITIGATION FUNDING PROVIDER] IN FULL, YOU WILL NOT 
10 OWE ANYTHING IN EXCESS OF YOUR RECOVERY."
11Sec. 10.  9-A MRSA §12-104-A is enacted to read:
12§12-104-A.  Prohibited conduct of litigation funding provider
131.  Prohibited conduct.  A litigation funding provider may not: 
14 A. Pay or offer to pay a commission, referral fee or other consideration to a person, 
15 including an attorney, law firm or health care practitioner, for referring a consumer to 
16 the litigation funding provider; 
17 B. Accept a commission, referral fee, rebate or other consideration from a person, 
18 including an attorney, law firm or health care practitioner; 
19 C. Advertise false or misleading information about the legal funding services of the 
20 litigation funding provider; 
21 D. Refer a consumer to a specific attorney, law firm or health care practitioner, except 
22 that, if a consumer lacks legal representation, the litigation funding provider may refer 
23 the consumer to an attorney referral service operated by a county or state bar 
24 association; 
25 E. Fail to promptly supply a copy of any complete legal funding contract to the 
26 consumer; 
27 F. Attempt to obtain a waiver of any remedy, including, but not limited to, 
28 compensatory, statutory or punitive damages, that a consumer might otherwise have in 
29 the subject civil claim or action; 
30 G. Attempt to effect arbitration or a waiver of a consumer's right to a jury trial in the 
31 subject civil claim or action; 
32 H. Offer or provide legal advice to a consumer regarding the legal funding contract or 
33 the subject civil claim or action; 
34 I. Assign a legal funding contract in whole or in part, including securitization; 
35 J. Report to a consumer credit reporting agency if insufficient funds remain from the 
36 net proceeds of the subject civil claim or action to repay the litigation funding provider; 
37 or
38 K. Direct or make any decisions with respect to the course of the subject civil claim or 
39 action or any settlement of the civil claim or action. 
Page 3 - 130LR2325(01)12.  Consideration to legal representative or health care practitioner prohibited.  A 
2 litigation funding provider, or its employees or affiliates, may not provide any financial 
3 interest in a legal funding contract or pay a referral fee or any other consideration to a legal 
4 representative retained by a consumer or a health care practitioner of a consumer or any of 
5 their employees.
6Sec. 11.  9-A MRSA §12-105-A is enacted to read:
7§12-105-A.  Legal funding contracts; disclosure and discovery
81.  Disclosure.  Except as otherwise ordered by a court, a consumer or the consumer's 
9 attorney shall, without awaiting a discovery request, provide to all parties to the litigation, 
10 including the consumer's insurer prior to the litigation, any legal funding contract under 
11 which a litigation funding provider has a contingent right to receive compensation sourced 
12 from potential proceeds of the civil claim or action by settlement, judgment or otherwise.
132.  Discovery.  The existence of a legal funding contract and all participants in the 
14 contract are permissible subjects of discovery in all personal injury litigation or matters 
15 arising out of a personal injury. 
163.  Class action.  In a class action, an attorney for a proposed class shall disclose to the 
17 court and any putative class member whether the class attorney has a legal or financial 
18 relationship with a litigation funding provider.
194.  Party to legal funding agreement.  If the consumer's attorney is a party to a legal 
20 funding contract related to the consumer's legal proceeding, the attorney shall disclose in 
21 writing to the consumer the contract between the attorney and the litigation funding 
22 provider. A copy of the contract must be accompanied by the written disclosure required 
23 by this subsection, and the consumer shall sign both an acknowledgment that the contract 
24 has been read and the required disclosure has been received.
25Sec. 12.  9-A MRSA §12-108 is enacted to read:
26§12-108.  Violation; enforcement
27 If a consumer, litigation funding provider or successor in interest to a legal funding 
28 contract violates any provision of this article, the legal funding contract may not be 
29 enforced by any party.
30SUMMARY
31 This bill updates the current law related to legal funding practices. The bill makes 
32 changes to the definitions to reflect changes in the industry, adds to the disclosures that 
33 must be made to consumers before entering into a legal funding contract and adds 
34 provisions related to prohibited conduct of a litigation funding provider. The bill provides 
35 that a legal funding contract must be disclosed to all parties to litigation by the consumer 
36 or the consumer's attorney, including to the consumer's insurer. The bill also provides that 
37 any violation of legal funding practices provisions makes the legal funding contract 
38 unenforceable.31
32
33
34
35
36
37
38
